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Abstract 
 
Aims: Hemodynamic nitrate tolerance has been shown to result in an insulin resistant state. 
We studied whether nitrate tolerance induced by a 7-day continuous exposure to transdermal 
nitroglycerin influenced the meal-induced insulin sensitization phenomenon in rabbits.  
Methods: Changes in insulin sensitivity in response to feeding in conscious rabbits were 
determined by rapid insulin sensitivity test, in both nitrate tolerant and non-tolerant animals. 
In a separate series of experiments with anaesthetized rabbits with or without nitrate 
tolerance, the hyperinsulinaemic euglycaemic glucose clamping methods was used to study 
the effect of intraportal infusion of cholecystokinin (CCK) on whole body insulin sensitivity. 
Results: Rabbits with normal feeding exhibited a 46 ± 6 % increase in insulin sensitivity as 
compared to their matching fasting control. A 7-day period of treatment with patches 
releasing 0.07 mg nitroglycerin per hour yielded nitrate tolerance and a state of insulin 
resistance and no increase in insulin sensitivity in response to food. Intraportal infusion of 
CCK8 (0.3-3.0 μg/kg over 20 min) resulted in a dose-dependent increase in insulin sensitivity 
in normal but not in nitrate tolerant fasted anaesthetized animals. 
Conclusions: Nitrate tolerance blocks both the meal-induced insulin sensitization 
phenomenon and the insulin sensitizing effect of intraportal cholecystokinin. 
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Abstract 
 
Aims: Hemodynamic nitrate tolerance has been shown to result in an insulin resistant state. 
We studied whether nitrate tolerance induced by a 7-day continuous exposure to transdermal 
nitroglycerin influenced the meal-induced insulin sensitization phenomenon in rabbits.  
Methods: Changes in insulin sensitivity in response to feeding in conscious rabbits were 
determined by rapid insulin sensitivity test, in both nitrate tolerant and non-tolerant animals. 
In a separate series of experiments with anaesthetized rabbits with or without nitrate 
tolerance, the hyperinsulinaemic euglycaemic glucose clamping methods was used to study 
the effect of intraportal infusion of cholecystokinin (CCK) on whole body insulin sensitivity. 
Results: Rabbits with normal feeding exhibited a 46 ± 6 % increase in insulin sensitivity as 
compared to their matching fasting control. A 7-day period of treatment with patches 
releasing 0.07 mg nitroglycerin per hour yielded nitrate tolerance and a state of insulin 
resistance and no increase in insulin sensitivity in response to food. Intraportal infusion of 
CCK8 (0.3-3.0 μg/kg over 20 min) resulted in a dose-dependent increase in insulin sensitivity 
in normal but not in nitrate tolerant fasted anaesthetized animals. 
Conclusions: Nitrate tolerance blocks both the meal-induced insulin sensitization 
phenomenon and the insulin sensitizing effect of intraportal cholecystokinin. 
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Introduction 
Organic nitrates constitute the mainstay therapy of angina pectoris and congestive 
heart failure. In addition to the therapeutically exploited cardiovascular effects, nitroglycerin, 
the prototype of nitrates used in human therapy has been shown to attain an insulin sensitizing 
effect in both experimental animals1 and healthy volunteers2. For convenience of chronic 
nitrate therapy, transdermal nitroglycerin delivery systems were developed to provide 
sustained effects. The resulting continuously high plasma concentration, however, was found 
to induce hemodynamic tolerance with an attenuation of the antianginal effect3,4. 
Subsequently, it has also been shown that hemodynamic nitrate tolerance blocks several 
endogenous adaptive mechanisms underpinned by nitric oxide (NO) release such as the anti-
ischemic effect of myocardial preconditioning5,6, the non-adrenergic, non-cholinergic 
relaxation of gastrointestinal sphincters7 and yields a state of insulin resistance1. The latter 
was suspected to somehow relate to the meal-induced insulin sensitization phenomenon first 
described by Sadri & Lautt8, since it was widely accepted that the phenomenon was the most 
effective NO-dependent endogenous insulin sensitizing mechanism.  
In a recent study, it has been described that the meal-induced endogenous insulin 
sensitizing mechanism can be blocked by proglumide, a cholecystokinin (CCK) receptor 
antagonist9. Results from another study with rats revealed that functional integrity of CCK1 
receptors is a prerequisite for the development meal-induced insulin sensitization10. Since NO 
of neural origin has been shown to be involved in the effects of CCK on gastrointestinal 
motility and secretion11,12, the present work was concerned with the possibility that the 
CCK-NO pathway was vulnerable to a state of hemodynamic nitrate tolerance. Thus, we 
devoted a series of experiments with rabbits to study whether nitrate tolerance, a state shown 
to deteriorate responses to both endogenous and exogenous NO, influenced the insulin 
sensitizing effect of either an exposure to meal or CCK infused into the portal vein.  
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Materials & Methods 
Ethical Issues and General Procedures 
The investigation conforms to the “Guide for the Care and Use of Laboratory 
Animals” published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996) and to the “Principles of laboratory animal care” (NIH publication No. 85-23, 
revised 1985). The experimental protocol applied has been approved by the local ethical 
board of the University of Debrecen, Hungary (license number: 6/2007/DE MÁB) 
 
Experimental animals 
Sixty-eight, adult, male New Zealand white rabbits, weighing 3 – 3.2 kg (Charles – 
Rivers Laboratories, Isaszeg, Hungary), housed in an animal room (12 – 12hour light/dark 
periods a day, temperature of 22 – 25°C, humidity of 50 – 70%) with one animal per pen 
(Techniplast, Italy), fed commercial laboratory chow (Charles-River Laboratories, Isaszeg, 
Hungary) and tap water ad libitum, were used throughout.  
 
Study Design  
After a 7-day period of acclimatization, the rabbits were tested for hypotensive 
response to a previously established intravenous 30 µg/kg test dose of nitroglycerin (Pohl-
Boskamp GmbH, Hohenlockstedt, Germany) applied over a period of 1 min13. The maximum 
decrease in blood pressure produced the data for evaluation. The rabbits exhibiting no 
significant decrease in blood pressure to the nitroglycerin test dose were excluded from 
further studies. The animals were then randomized into three main experimental groups. The 
group 1 animals entered the rapid insulin sensitivity test (RIST) series of experiments to study 
the effect of meal-induced insulin sensitization in starved animals (group 1a) and in those 
5 
 
with a re-exposure to food (group 1b). In this series of studies, changes in whole body insulin 
sensitivity were assessed by the RIST method in conscious animals, an approach specifically 
proposed to investigate the effect of food on insulin sensitivity14. The second main group of 
conscious animals entered the hyperinsulinaemic euglycaemic glucose clamp (HEGC) 
studies. In this latter series of experiments, whole body insulin sensitivity was determined in 
rabbits either starved (group 2a) or re-exposed to food (group 2b) by means of 
hyperinsulinaemic euglycaemic glucose clamping, a gold standard method for insulin 
sensitivity determinations in both human and whole animals15. The series of experiments with 
the third group of animals was devoted to study the effect of intraportal CCK infusion on 
insulin sensitivity in anaesthetized rabbits (thiopental 25 mg/kg i.v.) after a 24-h period of 
fasting. In these animals, CCK octapeptide sulphate (CCK8) was infused into the portal vein 
during the steady state of HEGC at 0.3, 1.0 and 3.0 μg/kg/h over 20 min in a cumulative 
manner. During the last minute of the highest infusion rate of CCK, hepatic samples were 
taken for cGMP determinations. For control to this series of rabbits served those with (4 
rabbits) and without nitrate tolerance (4 rabbits), which received vehicle infusion not 
succeeded by CCK8. This series of experiments was to confirm that intraportal CCK8 
infusion could attain an insulin sensitizing effect in fasting rabbits (Fig. 1).  
Each main group was further randomized in the same way as to whether the animals 
received either transdermal nitroglycerin (NG) patches releasing approximately 0.07 mg/kg/h 
nitroglycerin (Nitroderm TTS 5, Novartis Hungaria Budapest, Hungary) or matching placebo 
patches continuously over 7 days. Each patch was replaced daily with a new one. Either the 
RIST procedure (group 1 animals) or HEGC (group 2) was commenced 1 hour after removal 
of the last patch. After completion of either the RIST or HEGC determinations, we confirmed 
the presence or absence of nitrate tolerance by measuring changes in mean arterial blood 
pressure in response to the intravenous test dose (30 µg/kg body weight) of nitroglycerin in 
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the same way as accomplished prior to randomization to the main experimental groups. This 
occurred 4 hours after removal of the last (7th) patch.  
 
Verification of nitrate tolerance 
Animals were given transdermal nitroglycerin or placebo patches over 7 days to induce 
vascular tolerance to glyceryl trinitrate (GTN)16. Development of vascular tolerance to GTN 
was confirmed on the 7
th
 day by testing endothelium free carotid artery rings for isometric 
tension as described previously5,6. Rings of 5 mm in length were precontracted with an EC50 
concentration of norepinephrine in addition to a resting tension of 10 mN. The rings were then 
exposed to cumulative concentrations of GTN in half-log increments. The GTN 
concentrations required to produce half-maximal relaxation were 0.091 ± 0.012 mM in 
vehicle treated, non-tolerant rings versus 1.72 ± 0.19 mM in GTN-treated, tolerant ones 
(P<0.05). 
 
Rapid Insulin Sensitivity Test (RIST) 
Rapid insulin sensitivity test as previously described by Lautt et al.17 was preformed 
after minor modification according to different experimental species. In brief, an arterial and a 
venous cannula (Vygonüle V G22, Vygon GmbH &Co., Aachen, Germany) were introduced 
into the arteria and vena auricularis, respectively. Thereafter, animals were left for 30 minutes 
in order to stabilize their physiological parameters. Then arterial blood samples were taken at 
every 5 minutes for blood glucose determination. The mean blood glucose level of three 
consecutive measurements was referred to as the control value; afterwards, infusion of 50 
mU/kg insulin over 5 minutes was started. In order to counteract the hypoglycaemic effect of 
insulin, glucose infusion was also commenced and its rate was adjusted to maintain the 
control blood glucose level. The total amount of glucose (expressed as mg/kg body weight) 
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required to counteract the hypoglycaemic effect insulin and to maintain the control blood 
glucose level was expressed as RIST index, the indicator of whole body insulin 
sensitivity9,18. 
 
Hyperinsulinaemic Euglycaemic Glucose Clamp (HEGC) 
On one side, the arteria and vena auricularis was cannulated. The glucose and the 
insulin infusion lines were connected to a venous cannula by a 3-way stop cock (Tro-
venoflow 3, Troge Medical GmbH, Hamburg, Germany). After a 30 min stabilization period, 
human regular insulin (NOVO Nordisk, Copenhagen, Denmark) was infused (Syringe Pump 
11 Plus – Harvard Apparatus, Holliston, Massachusetts, USA) at a constant rate of 10 mU kg-
1 via one of the venous infusion line over 120 min. This insulin infusion rate yielded plasma 
insulin immunoreactivity of 100 5 μU/ml during the steady state. Blood samples (0.2 ml) 
were taken from the arterial cannula for blood glucose determination at 10 min intervals. 
Blood glucose concentration was maintained constant (5.5 0.5 mmol/L) by a variable rate of 
glucose infusion (Optima VS – Fresenius Kabi AG, Bad Homburg, Germany) via a second 
venous infusion line. When blood glucose had stabilized for at least 20 min, we defined this 
condition as steady state. This occurred within 100 min succeeding commencement of the 
insulin infusion. In the steady state, additional blood samples (0.2 ml) were taken for plasma 
insulin determination three times at 10-min intervals. The glucose infusion rate (mg/kg/min) 
during steady state was used to characterize insulin sensitivity15. Each clamp determination 
was done after a preceding 12-hour period of fasting. The arterial cannula besides serving for 
blood sampling also was used for monitoring the arterial blood pressure and heart rate. For 
this latter purpose, the arterial cannula was connected to a Statham P23DB transducer 
attached to an electromanometer (Experimetria Kft. Budapest, Hungary), as described 
previously 19. 
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Measurement of hepatic cGMP level 
Liver cGMP levels were determined from hepatic samples taken immediately after 
cessation of CCK8 infusion by means of radioimmunoassay as described previously19 using 
Amesham kits. The inter- and intra-assay variations did not exceed 5%. Sampling was done 
from animals with and without nitrate tolerance. 
 
Drugs and Chemicals 
The CCK octapeptide was purchased from Sigma-Aldrich Ltd. (Budapest, Hungary). 
Nitroglycerin patches were from Novartis (Basle, Switzerland) and nitroglycerin for 
intravenous use was from the Pohl-Boskamp GmbH (Hohenlockstedt, Germany). Glucose 
infusion was from Teva (Debrecen, Hungary). Human regular insulin was purchased from 
Novo Nordisk (Copenhagen, Denmark). 
 
Statistical analysis 
Data are expressed as means  S.D. of the mean were analysed with ANOVA 
followed by a modified t-test for paired data. P values were adjusted according to 
Bonferroni’s method20. 
 
Results 
Hemodynamic nitrate tolerance achieved by transdermal NG 
As shown by data in Table 1, transdermal NG produced a significant decrease in mean 
arterial blood pressure after the 1st patch on with no change in heart rate. The 3rd and the 7th 
patch on did not produce any change in these parameters. Thirty min after removal of the last 
patch, there were no changes in blood pressure and heart rate.  
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In untreated animals, the intravenous test dose of NG (30 µg/kg) decreased mean arterial 
blood pressure from 83 ± 5.1 and 86 ± 4.9 to 61 ± 4.4 and 60 ± 5.3 mmHg in those recruited 
into the groups being treated with NG releasing patches and placebo patches, respectively 
(P<0.01 for each). In rabbits treated with placebo patches over 7 days, the intravenous NG test 
dose decreased the ’patch off’’ blood pressure from 83 ± 4.8 to 60 ± 3.6 mmHg (P<0.01), 
whereas in animals treated with active patches, no change in blood pressure was seen in 
response to the test NG dose. This confirmed the fact of development of hemodynamic nitrate 
tolerance in the group of rabbits treated with active patches. 
Methaemoglobin formation did not exceed 1% over the study in either tolerant or non-tolerant 
animals. 
 
Insulin sensitivity reflected in the RIST index in fasted and re-fed animals with and without 
nitrate tolerance 
It is seen from data in Fig 2. that the RIST index was almost doubled in animals with 
placebo patches re-exposed food as compared to that measured with their fasting littermates. 
In rabbits with established hemodynamic nitrate tolerance, however, re-exposure to food was 
without effect on the RIST index. Fasting RIST values were lower in nitrate tolerant animals 
than those in the non-tolerant ones (Fig. 2).  
 
Insulin sensitivity measured by HEGC in fasted and re-fed animals with and without nitrate 
tolerance 
The data in Fig. 2. show that the glucose infusion rate needed to maintain euglycaemia 
at clamped hyperinsulinaemia increased with re-exposure to food as compared to 
corresponding fasting values in non-tolerant animals. This indicated an increase in whole 
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body insulin sensitivity in response to food. However, the food-induced insulin sensitization 
phenomenon was completely abolished in animals made nitrate tolerant.  
 
The insulin sensitizing effect of CCK8 during HEGC 
As shown by data in Fig. 3., CCK8 increased the rate of glucose infusion necessary to 
maintain euglycaemia during the steady state of the HEGC procedure in a dose-dependent 
manner. In rabbits with nitrate tolerance the CCK8 infusion produced no change in insulin 
sensitivity. 
 
The effect of CCK infusion on hepatic cGMP in rabbits with nitrate tolerance 
Hepatic cGMP level increased from 0.22 ± 0.07 and 0.13 ± 0.04 to 1.11 ± 0.09 and 
0.19 ± 0.04 pmol/mg wet tissue weight in response to 3 µg/kg/h CCK8 infusion (P<0.05 for 
both vs vehicle) in non-tolerant and tolerant animals, respectively. 
 
Discussion  
The results show that the state of hemodynamic nitrate tolerance achieved by a 7-day 
continuous exposure to transdermal nitroglycerin is associated with the loss of the meal-
induced insulin sensitization phenomenon in conscious rabbits. Beyond this original 
observation, the result confirm our previous results in that whole body insulin sensitivity 
determined in fasting rabbits is also significantly impaired when the animals are made tolerant 
to the hypotensive effect of transdermal nitroglycerin. An additional original observation is 
that the insulin sensitizing effect of intraportal CCK8 is impaired in nitrate tolerance. 
Considering that CCK can be considered a physiological trigger of post-prandial insulin 
sensitization, the present results represent a step forward in understanding mechanisms 
underlying the effect of meal on whole body insulin sensitivity in intact animals. 
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The concept that a deficiency in the NO-cGMP pathway of whatever origin yields a 
state of insulin resistance is not new. Petrie et al.21 measured insulin-mediated glucose 
disposal in healthy volunteers with the hyperinsulinaemic, euglycaemic clamp technique and 
defined the relationship between whole body sensitivity and an estimate of NO production. 
The major conclusion drawn was that a positive correlation existed between endothelial NO 
synthesis and insulin sensitivity in healthy volunteers. Subsequently, Piatti et al.22 reported 
that non-diabetic individuals with a positive family history of type 2 diabetes were insulin 
resistant, with deficient cGMP production at higher plasma NO concentrations, than that seen 
in healthy volunteers without a family history of diabetes. Under experimental conditions, 
allowing precise pharmacological analysis, NO synthase inhibitors apparently induced insulin 
resistance, and intraportal administration of NO donors restored physiological insulin 
sensitivity in rats8,23, rabbits24 and guinea-pigs25. In addition, studies with conscious rabbits 
revealed that the development of nitrate tolerance, a state known to be characterized by a 
substantial decrease in cGMP formation yielded insulin resistance1. This latter is strongly 
supported by results of the present work in terms of detecting relative insulin resistance in 
nitrate tolerant animals both in the fasting state and after meal.  
We think that the straightforward original observation of the present work is that the 
meal-induced insulin sensitizing mechanism is seriously impaired in nitrate tolerant rabbits. It 
is suspected that the meal-induced insulin sensitizing phenomenon is underlain by the release 
of a chemically undefined substance from the liver in response to food that sensitizes 
peripheral tissues, predominantly the skeletal muscle to the hypoglycaemic effect of insulin26. 
The substance has therefore been termed as a hepatic insulin sensitizing substance (HISS). 
Regarding the experimental approaches to study the HISS mechanism, Lautt et al. proposed 
the use of the rapid insulin sensitivity test27 instead of hyperinsulinaemic euglycaemic 
glucose clamping, the gold standard method of whole body insulin sensitivity determinations 
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in the clinical practice15. The RIST method utilizes hyperinsulinaemia produced by a short-
term insulin infusion (usually 5 min), the hypoglycaemic effect of which is compensated by a 
succeeding longer lasting glucose infusion17. During the hyperinsulinaemic clamp method, 
however, plasma insulin immunoreactivity is maintained at a level 10 or more times higher 
than corresponding fasting values with confirmation by succeeding radioimmunoassay 
determinations and accompanied by continuous glucose infusion. Assuming that the HISS 
mechanism was suspected to be activated at least in part by hyperinsulinaemia28, it might be 
postulated that a much higher degree of the HISS mechanism activation is achieved by 
clamping (because of the long-lasting stable hyperinsulinaemia) than by the RIST method. 
Nevertheless, in a recent study, we could not confirm the concept of hyperinsulinaemia-
induced activation of the HISS pathway29. Whatever the method used, the results clearly 
demonstrate that whole body insulin sensitivity is significantly increased when the animals 
are re-exposed to food after a preceding period of fasting and that this food-induced insulin 
sensitization phenomenon is blocked in nitrate tolerance. 
The present findings also seem to indirectly support the results by Peitl et al.10 in that 
CCK is of major influence on the postprandial insulin sensitization pathway. In their study, 
proglumide, a CCK receptor antagonist blocked the phenomenon of meal-induced insulin 
sensitization, and no change in insulin sensitivity was seen in response to food intake in 
animals without functioning CCK-1 receptors. As reads from data in Fig. 3 of the present 
work, stepwise increments in intraportal infusion of CCK8 produce a dose-dependent increase 
in whole body insulin sensitivity, an effect also completely blocked by nitrate tolerance. This 
is another original observation of the present work. Moreover, the results of experiments 
using HEGC and RIST together as end-points suggest for the first time that not only the post-
prandial, but baseline insulin sensitivity is decreased by nitrate tolerance. The precise 
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mechanism, however, responsible for the vulnerability of CCK effects to either NO synthase 
inhibition11 or nitrate tolerance, cannot be depicted based on results currently available.  
In a previous work carried out with isolated rabbit sphincter of Oddi preparations, we found 
that the contractile effect of CCK was not modified by nitrate tolerance 7. Therefore, a simple 
interaction between CCK receptor function and nitrate tolerance is unlikely to explain 
changes in CCK effects in other experiments. Under in vivo conditions, however, the complex 
motor effect of CCK strongly involves in the release/effect of NO 30, thus, the cross tolerance 
between exogenous and endogenous NO was striking at experimental paradigm different from 
the present design. Otherwise, the role of NO in hepatic insulin sensitization has been 
confirmed several times by various authors in various species8,24,31. Of course, it is more 
than possible that oxidative stress plays a role in this cross tolerance, possibly by neutralizing 
NO of whatever origin, by various biochemical mechanisms, and considering that reactive 
oxygen species are important mediators of nitrate tolerance, separate experiments were not 
directed towards analysing the role of oxidative stress on food-induced insulin sensitization in 
nitrate tolerance. In rabbits, changes in the metabolism of cGMP seem to be another important 
factor in desensitization of NO-dependent processes in nitrate tolerance. The cGMP 
phosphodiesterase inhibitors such as cicletanine and zaprinast were able to reverse 
haemodynamic nitrate tolerance in isolated vessels and gastrointestinal smooth muscle 
(unpublished observations). Based on the current results, it is impossible to provide 
explanation whether nitrate tolerance by what mechanism deteriorates the insulin sensitizing 
effect of intraportal CCK8. As CCK could achieve a much lower increase in hepatic tissue 
cGMP levels in tolerant than in non-tolerant animals, an increase in the breakdown of cGMP 
in nitrate tolerance cannot be excluded.  
 
Conclusions 
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Taken together, our results demonstrate for the first time, that the development of 
hemodynamic nitrate tolerance deteriorates the meal-induced insulin sensitization 
phenomenon in addition to decreasing whole body insulin sensitivity in fasting conscious and 
anaesthetized rabbits. Regarding the mechanisms behind, nitrate tolerance seems to seriously 
impair the insulin sensitizing effect of CCK. Considering that CCK is a major regulator of 
appetite32, post-prandial glucose production33 and gastrointestinal motility and secretion30, 
the interaction between nitrate tolerance and the effects of CCK released may explain 
metabolic complications of nitrate therapy34.  
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Figure legends 
 
 
Figure 1 shows the study design. Abbreviations: RIST: Rapid Insulin Sensitivity Test; HEGC: 
Hyperinsulinaemic Euglycaemic Glucose Clamping; the term “starved animals” is referred to 
as a 16-h period of fasting before either the RIST or the HEGC procedure; the re-fed rabbits 
were fasted over 14 h, than they were re-allowed to access to food for 2 h preceding the 
insulin sensitivity determination had been carried out; “+” indicates rabbits treated with 
nitroglycerin patches, “-“ indicates rabbits treated with placebo patches. 
 
 
Figure 2 shows the effect of nitrate tolerance on meal-induced insulin sensitization in rabbits. 
Whole body insulin sensitivity was determined in rabbits either starved (open bars or fasted) 
or re-exposed to standard food (squares columns or re-fed) by means of both 
hyperinsulinaemic euglycaemic glucose clamping (HEGC), and the rapid insulin sensitivity 
test (RIST). The term “Tolerant” means that the animals were made tolerant to the 
hypotensive effect of an intravenous dose of nitroglycerin (30 µg/kg) by a preceding 
continuous 7-day exposure to transdermal patches releasing approximately 0.07 mg/kg/h 
nitroglycerin. The “Non-tolerant” animals were exposed to matching placebo patches over 7 
days and exhibited a significant decrease in blood pressure in response to the intravenous 30 
µg/kg nitroglycerin test dose. Each column represents data obtained with a subgroup of 6 
rabbits. The data are means ± S.D. The asterisk: Re-fed vs fasted at P≤0.05; +: Tolerant vs 
non-tolerant at P≤0.05. 
 
 
Figure 3 shows the effect of nitrate tolerance on the insulin sensitizing effect of intraportal 
cholecystokinin octapeptide (CCK) in anaesthetized rabbits. CCK was infused into the portal 
vein in stepwise increments at doses 0.3-3.0 mg/kg/h during steady state of HEGC. The term 
22 
 
“Tolerant” means that the animals were made tolerant to the hypotensive effect of an 
intravenous dose of nitroglycerin (30 µg/kg) by a preceding continuous 7-day exposure to 
transdermal patches releasing approximately 0.07 mg/kg/h nitroglycerin. The “Non-tolerant” 
animals were exposed to matching placebo patches over 7 days and exhibited a significant 
decrease in blood pressure in response to the intravenous 30 µg/kg nitroglycerin test dose. 
The data are means ± S.D. obtained with subgroups of 6 rabbits The asterisk denotes a 
significant difference between GIR (glucose infusion rate) values obtained after a CCK dose 
vs vehicle at P≤0.05; + tolerant vs non tolerant at P≤0.05. 
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Figure 1. 
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Figure 2. 
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Figure 3. 
 
 
 
Table 
 
Mean Arterial Blood Pressure (mm Hg) 
------------------------------------------------------------------------------------------------------------------------------------------------------ 
 
Groups   Before patch  1st ’patch on 3rd ’patch on’ 7th ’patch on’  4 h after ’patch off ’ 
 
NG Patch  83 ± 5.1   69 ± 3.2*  85 ± 4.3   84±5.5  85±6.0 
Placebo   86 ± 4.9  85 ± 4.4   84 ± 5.5   82 ± 5.4   83 ± 4.8 
------------------------------------------------------------------------------------------------------------------------------------------------------ 
Heart Rate (b.p.m.) 
------------------------------------------------------------------------------------------------------------------------------------------------------ 
Groups   Before Patch  1st ’patch on’ 3rd ’patch on’ 7th ’patch on’ 3 h after ’patch off’  
NG Patch  236 ± 16  242 ± 18   244 ± 19   277 ± 14*  273 ± 14* 
Placebo   241 ± 22   248 ± 16   237 ± 22   248 ± 20   235 ± 18 
------------------------------------------------------------------------------------------------------------------------------------------------------ 
 
Table 1. shows the effect of Transdermal Nitroglycerin (NG) on Arterial Blood Pressure and 
Heart Rate in Conscious Rabbits The data are means ± SD obtained with 6 animals per group. 
*Significantly different from “before” values at P < 0.05. The data indicate maximum 
changes in blood pressure and heart rate that occurred within 30 min after patch on. Patch off 
values were determined 4 h after removal of the last patch. 
 
 
 
Table
